Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in the treatment of childhood autism
IRCT201202281556N37Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in Autism Spectrum Disorder (ASD), sponsored by Tehran University of Medical Sciences. Started Mar 2012; status: completed.
02
Drugs
pioglitazone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on IRCT201202281556N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202281556N37.